Mechanism of the persisting TxA2 receptor antagonism by picotamide.
Picotamide is a dual TxA2 receptor antagonist/TxA2 synthetase inhibitor. As the picotamide effect is maximum only after 5-10 min of incubation, aim of the present work was to study whether the effect of picotamide could be observed even after wash out of the drug from the external buffer. Platelet aggregation, serotonin release and changes in intracellular calcium were analyzed in platelets treated with picotamide and then gel-filtered, in comparison with gel-filtered platelets treated with picotamide. To exclude the possibility that the inhibitory effect of picotamide is due to its intracytosolic storage, serotonin release in digitonin-permeabilized platelets was measured. Platelet aggregation and serotonin release in response either to U46619, a synthetic agonist of the thromboxane A2 receptor, or arachidonic acid or collagen, as well as the changes in intracellular calcium concentration after U46619 or arachidonic acid stimulation, were inhibited by picotamide even when it had been washed out by gel-filtration. Both inhibitions were very similar to that observed in experiments in which picotamide was present in the medium. As the serotonin release in digitonin permeabilized platelets presented the same inhibition it may be excluded that picotamide effect is consequent upon the cytosolic storage of the drug. Since our results clearly indicate that the action of picotamide persists even after washing out of the drug from the medium, the idea that this antagonistic effect may be dependent on its binding to platelet plasma membrane rather than on its cytosolic concentration, is strongly substantiated.
Pulcinelli
F M
FM
Dept. of Experimental Medicine, University of Rome La Sapienza, Italy.
Pignatelli
P
P
Pesciotti
M
M
Sebastiani
S
S
Parisi
S
S
Gazzaniga
P P
PP
D001792:Blood Platelets / Q000378:metabolism; D002118:Calcium / Q000378:metabolism; D004072:Digitonin / Q000494:pharmacology; D006801:Humans; D066298:In Vitro Techniques; D010795:Phthalic Acids / Q000494:pharmacology*; D010974:Platelet Aggregation / Q000187:drug effects; D010975:Platelet Aggregation Inhibitors / Q000494:pharmacology*; D017482:Receptors, Thromboxane / Q000037:antagonists & inhibitors*; D012701:Serotonin / Q000097:blood
D010795:Phthalic Acids; D010975:Platelet Aggregation Inhibitors; D017482:Receptors, Thromboxane; D012701:Serotonin; C011581:picotamide; D004072:Digitonin; D002118:Calcium